Medicine News and Research

RSS

Statistical modeling used to estimate benefits and risks of PSA screening

Men largely make decisions about prostate cancer screening based on conversations with their clinicians, but these discussions often do not include information about the risks of testing in addition to the benefits, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2009

Januvia in combination with metformin or taken alone lowers blood sugar

A post-hoc analysis, presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD), of data pooled from studies of 104 weeks in duration showed ‘Januvia’ (sitagliptin), when taken alone or in combination with metformin, provided significant blood sugar lowering over two years.

29 Sep 2009

Continuous chest compressions during CPR improve survival rates during cardiac arrest

Maximizing the proportion of time spent performing chest compressions during cardiopulmonary resuscitation (CPR) substantially improves survival in patients who suffer cardiac arrest outside a hospital setting, according to a multicenter clinical study that included UT Southwestern Medical Center.

29 Sep 2009

Minimally invasive mitral valve surgery is safe and effective

Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. The majority of those procedures are open-heart operations that require a major incision in the chest. Now, after a six-year study, surgeons at the University of Maryland Medical Center in Baltimore conclude that minimally invasive mitral valve repair techniques, through only a two-inch incision in the right side of the chest, are safe, durable and effective. The results are published in the September 2009 Annals of Surgery.

29 Sep 2009

Biochemistry professor to discuss controversies in dietary strategies in diabetes treatment

Richard Feinman, PhD, professor of biochemistry and of family medicine at SUNY Downstate Medical Center in Brooklyn, New York, will speak at the annual conference of the European Association for the Study of Diabetes (EASD) on October 2, 2009. EASD is holding its annual conference September 28 - October 2 in Vienna, Austria.

29 Sep 2009

Estrogen withdrawal may play a significant role in joint pain during breast cancer treatment

Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.

29 Sep 2009

Researchers recommend hormone therapy prior to mammogram screenings

Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.

29 Sep 2009

Proton therapy center to treat pediatric and adult cancer patients

The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.

29 Sep 2009

NIH awards Johns Hopkins Epigenetic Center $16.8M to advance genomics research

Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.

29 Sep 2009

Abnormal results on outpatient imaging tests may not receive timely follow-up, says report

Abnormal results on outpatient imaging tests sometimes may not receive timely follow-up even when clinicians receive and read results in an advanced, integrated electronic medical record system, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2009

UCLA discovery raises hope for curing genetic disorders caused by nonsense mutations

UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.

29 Sep 2009

Hospital-at-home care favorable to traditional hospital care

Hospital-at-home care may be a practical alternative to traditional hospital inpatient care for patients with acutely decompensated (suddenly worsening) chronic heart failure, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2009

Medical experts explore future of health advancements at Military Medicine Symposium

Renowned military, government and civilian medical experts will discuss advances in posttraumatic stress disorder, traumatic brain injury, humanitarian assistance and global infectious disease and explore the collaborative future of health advancements at the Partnership for Military Medicine Symposium on Nov. 6 at the Omni Shoreham in Washington, D.C.

29 Sep 2009

Kane Biotech's Dispersinb Topical Wound Gel passes cytotoxicity and primary skin irritation tests

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.

28 Sep 2009

NIH funds Brown University's Samoan genotyping project

Do some people have special "susceptibility" genes that make them vulnerable to obesity and diabetes, triggered by poor diet and less exercise?

28 Sep 2009

Dialysis patients often not told about transplant options, Newspaper finds

"Thousands of kidney patients in the United States start dialysis without first being told of kidney transplants that would be cheaper and lead to longer lives, according to a four-month newspaper investigation published Sunday," The Associated Press reports.

28 Sep 2009

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.

28 Sep 2009

UNC awarded $8.6M for a new Center for Integrated Systems Genetics

Autism, depression, anxiety. Antipsychotic drug side effects. What are the genetic and environmental factors that underlie and contribute to these complex problems? And how do genes and environment interact to shape them?

28 Sep 2009

Private health system takes root in British Columbia

The Los Angeles Times reports that consumers in Canada are "beginning to flirt with private-sector medicine."

28 Sep 2009

Merck to distribute Afluria in the U.S. for CSL Biotherapies

CSL Biotherapies and its parent company, CSL Limited, one of the world's leading manufacturers of influenza vaccine, have reached an agreement with Merck & Co., Inc. on rights to market and distribute Afluria® in the United States under an exclusive, six-year agreement effective September 3, 2009.

28 Sep 2009

Medicine News and Research

Statistical modeling used to estimate benefits and risks of PSA screening

Januvia in combination with metformin or taken alone lowers blood sugar

Continuous chest compressions during CPR improve survival rates during cardiac arrest

Minimally invasive mitral valve surgery is safe and effective

Biochemistry professor to discuss controversies in dietary strategies in diabetes treatment

Estrogen withdrawal may play a significant role in joint pain during breast cancer treatment

Researchers recommend hormone therapy prior to mammogram screenings

Proton therapy center to treat pediatric and adult cancer patients

NIH awards Johns Hopkins Epigenetic Center $16.8M to advance genomics research

Abnormal results on outpatient imaging tests may not receive timely follow-up, says report

UCLA discovery raises hope for curing genetic disorders caused by nonsense mutations

Hospital-at-home care favorable to traditional hospital care

Medical experts explore future of health advancements at Military Medicine Symposium

Kane Biotech's Dispersinb Topical Wound Gel passes cytotoxicity and primary skin irritation tests

NIH funds Brown University's Samoan genotyping project

Dialysis patients often not told about transplant options, Newspaper finds

NIH awards DiscoveryBioMed a Phase 2 SBIR grant for research on hypertension and cystic fibrosis

UNC awarded $8.6M for a new Center for Integrated Systems Genetics

Private health system takes root in British Columbia

Merck to distribute Afluria in the U.S. for CSL Biotherapies

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News